193 related articles for article (PubMed ID: 38668337)
21. Advanced glycation end products in the pathogenesis of chronic kidney disease.
Rabbani N; Thornalley PJ
Kidney Int; 2018 Apr; 93(4):803-813. PubMed ID: 29477239
[TBL] [Abstract][Full Text] [Related]
22. Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology.
Berner AK; Brouwers O; Pringle R; Klaassen I; Colhoun L; McVicar C; Brockbank S; Curry JW; Miyata T; Brownlee M; Schlingemann RO; Schalkwijk C; Stitt AW
Diabetologia; 2012 Mar; 55(3):845-54. PubMed ID: 22143324
[TBL] [Abstract][Full Text] [Related]
23. Identification of glyoxalase 1 polymorphisms associated with enzyme activity.
Peculis R; Konrade I; Skapare E; Fridmanis D; Nikitina-Zake L; Lejnieks A; Pirags V; Dambrova M; Klovins J
Gene; 2013 Feb; 515(1):140-3. PubMed ID: 23201419
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of glyoxalase 1 overexpression on diabetic atherosclerosis and renal dysfunction in streptozotocin-treated, apolipoprotein E-deficient mice.
Geoffrion M; Du X; Irshad Z; Vanderhyden BC; Courville K; Sui G; D'Agati VD; Ott-Braschi S; Rabbani N; Thornalley PJ; Brownlee M; Milne RW
Physiol Rep; 2014 Jun; 2(6):. PubMed ID: 24920125
[TBL] [Abstract][Full Text] [Related]
25. Glyoxalase I reduces glycative and oxidative stress and prevents age-related endothelial dysfunction through modulation of endothelial nitric oxide synthase phosphorylation.
Jo-Watanabe A; Ohse T; Nishimatsu H; Takahashi M; Ikeda Y; Wada T; Shirakawa J; Nagai R; Miyata T; Nagano T; Hirata Y; Inagi R; Nangaku M
Aging Cell; 2014 Jun; 13(3):519-28. PubMed ID: 24612481
[TBL] [Abstract][Full Text] [Related]
26. Methylglyoxal and glyoxalase 1-a metabolic stress pathway-linking hyperglycemia to the unfolded protein response and vascular complications of diabetes.
Rabbani N
Clin Sci (Lond); 2022 Jun; 136(11):819-824. PubMed ID: 35635155
[TBL] [Abstract][Full Text] [Related]
27. A Glyoxalase-1 Knockdown Does Not Have Major Short Term Effects on Energy Expenditure and Atherosclerosis in Mice.
Wortmann M; Hakimi M; Fleming T; Peters AS; Sijmonsma TP; Herzig S; Nawroth PP; Böckler D; Dihlmann S
J Diabetes Res; 2016; 2016():2981639. PubMed ID: 26788517
[TBL] [Abstract][Full Text] [Related]
28. The GLO1 C332 (Ala111) allele confers autism vulnerability: family-based genetic association and functional correlates.
Gabriele S; Lombardi F; Sacco R; Napolioni V; Altieri L; Tirindelli MC; Gregorj C; Bravaccio C; Rousseau F; Persico AM
J Psychiatr Res; 2014 Dec; 59():108-16. PubMed ID: 25201284
[TBL] [Abstract][Full Text] [Related]
29. Gene doubling increases glyoxalase 1 expression in RAGE knockout mice.
Bartling B; Zunkel K; Al-Robaiy S; Dehghani F; Simm A
Biochim Biophys Acta Gen Subj; 2020 Jan; 1864(1):129438. PubMed ID: 31526867
[TBL] [Abstract][Full Text] [Related]
30. Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics.
Rabbani N; Xue M; Thornalley PJ
Glycoconj J; 2016 Aug; 33(4):513-25. PubMed ID: 27406712
[TBL] [Abstract][Full Text] [Related]
31. Dicarbonyl-mediated AGEing and diabetic kidney disease.
Dimitropoulos A; Rosado CJ; Thomas MC
J Nephrol; 2020 Oct; 33(5):909-915. PubMed ID: 32170575
[TBL] [Abstract][Full Text] [Related]
32. Insulin resistance in lean and overweight non-diabetic Caucasian adults: Study of its relationship with liver triglyceride content, waist circumference and BMI.
Gonzalez-Cantero J; Martin-Rodriguez JL; Gonzalez-Cantero A; Arrebola JP; Gonzalez-Calvin JL
PLoS One; 2018; 13(2):e0192663. PubMed ID: 29425212
[TBL] [Abstract][Full Text] [Related]
33. Glyoxalase I is a novel target for the prevention of metabolic derangement.
Miranda ER; Haus JM
Pharmacol Ther; 2023 Oct; 250():108524. PubMed ID: 37722607
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin II reduces glyoxalase 1 activity and expression in vascular smooth muscle cells: Implications for diabetic vascular complications.
Kırça M; Yeşilkaya A
Cell Biochem Funct; 2023 Dec; 41(8):1430-1441. PubMed ID: 37915258
[TBL] [Abstract][Full Text] [Related]
35. Generation and characterization of mouse knockout for glyoxalase 1.
Jang S; Kwon DM; Kwon K; Park C
Biochem Biophys Res Commun; 2017 Aug; 490(2):460-465. PubMed ID: 28623132
[TBL] [Abstract][Full Text] [Related]
36. Impact of GLO1 knock down on GLUT4 trafficking and glucose uptake in L6 myoblasts.
Engelbrecht B; Stratmann B; Hess C; Tschoepe D; Gawlowski T
PLoS One; 2013; 8(5):e65195. PubMed ID: 23717693
[TBL] [Abstract][Full Text] [Related]
37. Glyoxylase-1 combats dicarbonyl stress and right ventricular dysfunction in rodent pulmonary arterial hypertension.
Prisco SZ; Hartweck L; Keen JL; Vogel N; Kazmirczak F; Eklund M; Hemnes AR; Brittain EL; Prins KW
Front Cardiovasc Med; 2022; 9():940932. PubMed ID: 36093169
[TBL] [Abstract][Full Text] [Related]
38. Increased peritoneal damage in glyoxalase 1 knock-down mice treated with peritoneal dialysis.
Kihm LP; Müller-Krebs S; Holoch S; Schmuck S; Becker LE; Brownlee M; Zeier M; Fleming TH; Nawroth PP; Schwenger V
Nephrol Dial Transplant; 2015 Mar; 30(3):401-9. PubMed ID: 25387474
[TBL] [Abstract][Full Text] [Related]
39. Dicarbonyl stress, protein glycation and the unfolded protein response.
Rabbani N; Xue M; Thornalley PJ
Glycoconj J; 2021 Jun; 38(3):331-340. PubMed ID: 33644826
[TBL] [Abstract][Full Text] [Related]
40. Glyoxalase 1 as a Therapeutic Target in Cancer and Cancer Stem Cells.
Kim JY; Jung JH; Lee SJ; Han SS; Hong SH
Mol Cells; 2022 Dec; 45(12):869-876. PubMed ID: 36172978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
